DEUTSCHE BANK AG\ - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 76 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$39,000
-53.0%
11,140
-10.6%
0.00%
Q4 2021$83,000
-29.7%
12,458
+5.6%
0.00%
Q3 2021$118,000
-50.6%
11,800
+52.4%
0.00%
Q2 2021$239,000
-55.6%
7,742
-37.2%
0.00%
Q1 2021$538,000
+131.9%
12,330
+146.6%
0.00%
Q4 2020$232,0005,0000.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders